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Infectious Disease Epidemiology Report
Haemophilus influenzae, Maine 2012

The Infectious Disease Epidemiology Program of
the Maine Center for Disease Control and
Prevention (Maine CDC) monitors the incidence of
invasive Haemophilus influenzae (H. influenzae)
through mandatory reporting by healthcare
providers, clinical laboratories, and other public
health partners. This report summarizes
surveillance data on cases of invasive H. influenzae
from 2012.
Haemophilus influenzae disease is caused by
Haemophilus influenzae bacteria. It can be spread
from person to person through droplets in the air
when a person who is infected sneezes or coughs.
The bacteria can cause meningitis and infections in
joints, lungs, and blood.

Methods
Cases of invasive H. influenzae are defined as
persons with isolation of H. influenzae from a
normally sterile site (e.g. blood or cerebrospinal
fluid or, less commonly, joint, pleural, or pericardial
fluid). Standardized case report forms were
completed for each case in 2012. Serotyping was
performed on H. influenzae isolates at Maine’s
Health and Environmental Testing Laboratory
(HETL). Rates were calculated using 2012 US
census population estimates.

Results
A total of 23 cases of invasive H. influenzae were
reported in Maine in 2012. This is three fewer
cases than were reported in 2011. The 2012 rate
of H. influenzae in Maine was 1.7 cases per
100,000 population which is a decrease from 2.0 in
2011 (Figure 1). The 2012 US rate was 1.1 cases
per 100,000 population.

Figure 1: Rate of invasive H. influenzae by year –
Maine, 2007-2012
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The age range of all cases was 6 days to 93 years,
and the median age was 66 years. Three cases
were H. influenzae serotype b (Hib) (Table 1).
There were no cases of Hib in children.
Table 1: Number of invasive H. influenzae cases by
age and serotype – Maine, 2012

Age
(years)

B

Non-B

<5
5-17
18-34
35-44
45-64
>65

0
0
0
0
1
2
3

1
0
0
1
3
6
11

Total

Serotype
NonTypeable

1
0
1
0
2
4
8

Unknown*

Total

0
0
0
0
0
1
1

2
0
1
1
6
13
23

*Unknown due to sample not being sent to HETL for testing.

Of the 23 invasive H. influenzae cases reported in
2012, 9 had bacteremia, 17 had pneumonia, 2 had
meningitis, and 1 had sepsis. Four deaths were
associated with invasive H. influenzae disease in
2012.
Invasive H. influenzae disease was identified
among residents in 11 of 16 Maine counties (Figure
2).

Figure 2: Invasive H. influenzae cases – Maine, 2012
(N=23)
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Persons older than 59 months of age
who have high-risk conditions including
sickle cell disease, HIV/AIDS, asplenia,
bone marrow transplant, or are immune
compromised.

Hib vaccine is not recommended for healthy
persons older than 59 months of age.
Maintaining high vaccination rates, particularly
among children in child care settings, is important
to prevent Hib. There are no vaccines for use
against non-serotype b disease.
All cases of invasive H. influenzae disease in Maine
must be reported by calling 1-800-821-5821, or by
faxing reports to 1-800-293-7534. For more
information, contact your healthcare provider or
local health center.
Additional information about H. influenzae can be
found at:
• Maine CDC
http://www.maine.gov/dhhs/mecdc/infectiou
s-disease/epi/airborne/haemophilus.shtml
• Federal CDC
http://www.cdc.gov/vaccines/vpdvac/hib/default.htm

Discussion
H. influenzae serotype b is vaccine preventable. In
2012, there were no Hib cases identified in infants
or young children in Maine. Unvaccinated
household and child care contacts of a known Hib
case are at higher risk for disease because the
bacteria are spread from person to person by
airborne droplets through coughing or sneezing.
Prophylaxis with antibiotics is recommended for all
household members and close contacts of
someone diagnosed with Hib disease only if there
is
• at least one unvaccinated child under 4
years of age or
• a child or adult with a weak immune system
in the home.
A vaccine against Hib is available in the United
States and is recommended for the following
individuals:
• All infants beginning at 2 months of age.
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